Molecular Imaging Research Program

Mission

The goals of the Molecular Imaging (MI) Program include the development and testing of new imaging methods ranging from preclinical work on the synthesis of new probes and development of new devices to the clinical evaluation of imaging approaches to assess cancer risk, detect cancer, guide treatment and monitor therapy. These imaging methods are aimed at improving our understanding of cancer physiology and providing for the integration of these findings to ultimately improve the assessment of cancer and its treatment. To achieve these goals we have two themes. 

Scientific Themes

  • Theme 1. Synthesis of new imaging agents for metabolism and drug pharmacodynamics
  • Theme 2. Implement and test new imaging agents and methods for risk assessment, detection, guidance and assessment of the response to therapy
  • Theme 3. Develop and test novel instrumentation for molecular imaging

Program Activities

The MI Program works to bring investigators together to expand collaborative activities with members of our program and other programs through:

  • Monthly program meetings which include speakers from within the MI Program, speakers from related disciplines and invited outside speakers. 
  • Joint meetings or mini-retreats with other programs to highlight particular areas of collaboration. 
  • Yearly retreats are held for the program to further foster collaboration among members
  • Organization of working groups to evaluate joint projects including multi-investigator pilot projects, protocols, and grants. 

Program Leaders

  • Nerissa Viola, Ph.D.

    Leader, Molecular Imaging Program
    Karmanos Cancer Institute
    Wayne State University School of Medicine

  • Anthony Shields, M.D., Ph.D.

    Co-Leader, Molecular Imaging Program
    Karmanos Cancer Institute
    Wayne State University School of Medicine

The Latest From Karmanos Cancer Institute

News

IN THE NEWS: Surviving Lung Cancer Focused Morhaf Al Achkar’s Career on Addressing Health Disparities

Cancer History Project Morhaf Al Achkar, M.D., Ph.D., MSCR, FAAFP, associate center director of Education at the Barbara Ann Karmanos Cancer Insti...

Read More

IN THE NEWS – Ovarian Suppression: Benefits, Side Effects, and Treatment

Patient Power Ovarian suppression is a treatment that stops estrogen from being produced in a woman’s ovaries. Jailan Elayoubi, M.D. , medical onc...

Read More

Volunteer Brings Hope Through Experience to Patients Battling Cancer

On any given Friday, you will find Loraine Roberts at Karmanos Cancer Institute at McLaren Flint. She's not a patient; she is one of eight McLaren...

Read More
News

Cancer History Project | Surviving Lung Cancer Focused Morhaf Al Achkar’s Career on Addressing Health Disparities

Listen Now

WOLB | Prostate Cancer Among African American Men

Listen Now

WWJ | Karmanos Seeks 20 Cancer Survivors for Commerce Township Fitness Classes

Listen Now